BANK VONTOBEL/CALL/INTUITIVE SURGICAL/500/0.1/20.12.24 Share Price

Warrant

DE000VD3VX24

Real-time Boerse Frankfurt Warrants 08:33:03 21/05/2024 pm IST
0.99 EUR -1.98% Intraday chart for BANK VONTOBEL/CALL/INTUITIVE SURGICAL/500/0.1/20.12.24
Current month+40.28%
1 month+32.89%
Date Price Change
21/24/21 0.99 -1.98%
20/24/20 1.01 +2.02%
17/24/17 0.99 -1.98%
16/24/16 1.01 0.00%
15/24/15 1.01 +38.36%

Real-time Boerse Frankfurt Warrants

Last update May 21, 2024 at 08:33 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying INTUITIVE SURGICAL, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VD3VX2
ISINDE000VD3VX24
Date issued 10/04/2024
Strike 500 $
Maturity 20/12/2024 (213 Days)
Parity 10 : 1
Emission price 1.21
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 1.5
Lowest since issue 0.67
Delta0.23x
Omega 8.452
Premium28.24x
Gearing37.05x
Moneyness 0.7966
Difference Strike 101.5 $
Difference Strike %+20.30%
Spread 0.02
Spread %2.00%
Theoretical value 1.000
Implied Volatility 29.64 %
Total Loss Probability 83.29 %
Intrinsic value 0.000000
Present value 1.000
Break even 510.85 €
Theta-0.05x
Vega0.09x
Rho0.04x

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
400 USD
Average target price
420.4 USD
Spread / Average Target
+5.09%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW